TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15521804

Group type: EXPERIMENTAL
Intervention: Full report of the entire list
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Final word report
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated words presented in sentences
Number of subjects: 0
Study: 11305982

Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (target heart rate 85% +/- 5 beats/min)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Low-intensity exercise program (target heart rate 50% VO(2 max) +/- 5 beats/min)
Number of subjects: 185
Study: 9328304

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 10-15 mg/kg/d
Number of subjects: 52
Study: 8405741

Group type: EXPERIMENTAL
Intervention: GLP-1 (7-36 amide) infusion at 1.2 pmol x kg‐1 x min‐1
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 10
Study: 3910836

Group type: EXPERIMENTAL
Intervention: Prednisone 15 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30962946

Group type: EXPERIMENTAL
Intervention: Alcohol-based hand rub (ABHR) provided to postpartum mothers, with instructions on use and training.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard care (control group) without ABHR.
Number of subjects: 103
Study: 29089172

Group type: EXPERIMENTAL
Intervention: Nonrebreather mask with flush rate oxygen (40 to 60 L/min)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Bag-valve mask with flush rate oxygen (40 to 60 L/min)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Bag-valve mask with simulated mask leak
Number of subjects: 57

Group type: COMPARATOR
Intervention: Bag-valve mask with inspiratory assistance
Number of subjects: 57
Study: 25391264

Group type: EXPERIMENTAL
Intervention: Short lymphoscintigraphy protocol (0-2 mL of unfiltered technetium sulphur colloid injected the morning before surgery)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Long lymphoscintigraphy protocol (0-2 mL of unfiltered technetium sulphur colloid injected the day before surgery)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Combined technetium/patent blue labeling technique
Number of subjects: 133

Group type: COMPARATOR
Intervention: Both short and long lymphoscintigraphy protocols
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Lymphoscintigraphy
Number of subjects: 133
Study: 22890087

Group type: EXPERIMENTAL
Intervention: Piezoelectric device
Number of subjects: 52

Group type: COMPARATOR
Intervention: Rotatory instruments
Number of subjects: 52

Group type: COMPARATOR
Intervention: Burr (rotatory instruments)
Number of subjects: 52
Study: 22092476

Group type: EXPERIMENTAL
Intervention: OFD + rhGDF-5/β-TCP (n=10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: OFD alone (control; n=10)
Number of subjects: 20
Study: 19651944

Group type: EXPERIMENTAL
Intervention: Standard posterior cruciate-retaining total knee prosthesis
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: High-flexion posterior cruciate-retaining total knee prosthesis
Number of subjects: 54
Study: 17334317

Group type: EXPERIMENTAL
Intervention: Active low-frequency rTMS
Number of subjects: 4

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 4
Study: 14987278

Group type: EXPERIMENTAL
Intervention: Local KUVA treatment
Number of subjects: 33

Group type: COMPARATOR
Intervention: Systemic PUVA treatment
Number of subjects: 33
Study: 11256551

Group type: EXPERIMENTAL
Intervention: Intervention group (nurse-run asthma education program)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 28
Study: 7748631

Group type: EXPERIMENTAL
Intervention: Shared care
Number of subjects: 554

Group type: COMPARATOR
Intervention: Outpatient clinic follow-up
Number of subjects: 554

Group type: COMPARATOR
Intervention: Nurse practitioner clinic
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: General practitioners' participation
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Patient acceptability of shared care
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Patient preference for follow-up method
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness ranking
Number of subjects: 554
Study: 3379743

Group type: EXPERIMENTAL
Intervention: Empirical regimen (4.8 million U of aqueous penicillin G procaine intramuscularly and 1.0 g of probenecid orally, followed by 100 mg of oral doxycycline twice daily for seven days)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Specific therapy for each infection as it was recognized
Number of subjects: 129
Study: 31008797

Group type: EXPERIMENTAL
Intervention: Pre-ART IL-6
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Pre-ART TNFα
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Baseline CRP
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Baseline IL-6
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: CRP, IL-6, soluble CD14, TNFα, HIV viral load (between weeks 0 and 4)
Number of subjects: 613
Study: 28527549

Group type: EXPERIMENTAL
Intervention: 1 g of intravenous acetaminophen
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 26083959

Group type: EXPERIMENTAL
Intervention: Patient-initiated brief intervention (BI)
Number of subjects: 267
Study: 23291972

Group type: EXPERIMENTAL
Intervention: Hemostatic matrix (HM)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Electrosurgical bipolar coagulation (EBC)
Number of subjects: 30
Study: 21915483

Group type: EXPERIMENTAL
Intervention: Motor intervention (aerobic exercises including flexibility, strength, agility, and functional balance exercises) for 6 months, 60 minutes three times per week
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Motor intervention (aerobic exercises)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study: 19230469

Group type: EXPERIMENTAL
Intervention: Capsitol‐Enabled Budesonide Inhalation Solution (CBIS) 120 microg twice daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Pulmicort Respules (budesonide suspension) 500 microg twice daily
Number of subjects: 17
Study: 17035697

Group type: EXPERIMENTAL
Intervention: Intravenous iron (sodium ferric gluconate complex) 250 mg i.v. weekly x 4
Number of subjects: 75

Group type: COMPARATOR
Intervention: Oral iron (ferrous sulfate) 325 mg t.i.d. x 42 days
Number of subjects: 75
Study: 12832708

Group type: EXPERIMENTAL
Intervention: Aquatic training programme (1 hour per week for approximately 20 sessions)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 54
Study: 10616844

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 352

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 352
Study: 9228490

Group type: EXPERIMENTAL
Intervention: Childbirth preparation with the Lamaze method
Number of subjects: 47

Group type: COMPARATOR
Intervention: No childbirth preparation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Behavior during labor (regardless of group)
Number of subjects: 47
Study: 7960018

Group type: EXPERIMENTAL
Intervention: 235T allele frequency in hypertensive group (83%)
Number of subjects: 187

Group type: COMPARATOR
Intervention: 235T allele frequency in normotensive group (82%)
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 174M allele frequency in hypertensive group
Number of subjects: 187

Group type: COMPARATOR
Intervention: 174M allele frequency in normotensive group
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 235T allele frequency in Nigerian sample (93%)
Number of subjects: 187
Study: 3331045

Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin (0.5 g six hourly)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Combination therapy (ampicillin 0.5 g six hourly, metronidazole 0.5 g eight hourly, gentamicin 80 mg eight hourly)
Number of subjects: 45
Study: 29126824

Group type: EXPERIMENTAL
Intervention: Seventeen Days (treatment intervention; sex education)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Driving Skills for Life (control intervention; driving education)
Number of subjects: 100
Study: 27866133

Group type: EXPERIMENTAL
Intervention: Complete revascularisation during a staged procedure before discharge
Number of subjects: 627

Group type: COMPARATOR
Intervention: IRA-PCI only
Number of subjects: 627

Group type: EXPERIMENTAL
Intervention: Complete revascularisation
Number of subjects: 627
Study: 26690812

Group type: EXPERIMENTAL
Intervention: Oral antibiotics for the first 6 weeks of therapy
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Intravenous antibiotics for the first 6 weeks of therapy
Number of subjects: 1050
Study: 23201175

Group type: EXPERIMENTAL
Intervention: Loperamide (70-100mg per day)
Number of subjects: 258
Study: 22192273

Group type: EXPERIMENTAL
Intervention: MINT-TLC (therapeutic lifestyle intervention)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 200
Study: 18326990

Group type: EXPERIMENTAL
Intervention: Telemonitoring by an advanced practice nurse
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 102
Study: 17002724

Group type: EXPERIMENTAL
Intervention: AS + AQ
Number of subjects: 180

Group type: COMPARATOR
Intervention: AS + SP
Number of subjects: 180
Study: 14570676

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.27% wt/vol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.31% wt/vol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Levobupivacaine/bupivacaine potency ratio
Number of subjects: 60
Study: 11053761

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (8 weeks)
Number of subjects: 208
Study: 8880820

Group type: EXPERIMENTAL
Intervention: Midazolam loading dose 0.08 mg.kg‐1
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Midazolam loading dose 0.04 mg.kg‐1
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (0.00 mg.kg‐1)
Number of subjects: 23
Study: 8299441

Group type: EXPERIMENTAL
Intervention: Erythromycin (250 mg 3 times/day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg 3 times/day)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Erythromycin and Metoclopramide
Number of subjects: 13
Study: 3522372

Group type: EXPERIMENTAL
Intervention: Weekly endoscopic sclerotherapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Three weeks endoscopic sclerotherapy
Number of subjects: 96
Study: 29526840

Group type: EXPERIMENTAL
Intervention: High intensity training (HIT) - 100% VO2Max cardiovascular and 80% 1RM resistance training, 12 sessions, 1.5 hours/session, 2 x/week for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Average intensity/load conventional physical therapy (CON) - 60% VO2max
Number of subjects: 20
Study: 27288375

Group type: EXPERIMENTAL
Intervention: Antenatal education in small classes (3 sessions of 2.5 hours each)
Number of subjects: 1766

Group type: COMPARATOR
Intervention: Standard auditorium-based lectures (2 sessions of 2 hours each)
Number of subjects: 1766
Study: 25011274

Group type: EXPERIMENTAL
Intervention: Safflower treatment group
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: PCI group
Number of subjects: 93
Study: 22591582

Group type: EXPERIMENTAL
Intervention: Home-based obesity prevention intervention
Number of subjects: 225

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 225
Study: 20541263

Group type: EXPERIMENTAL
Intervention: Inverted internal limiting membrane (ILM) flap technique
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard 3-port pars plana vitrectomy with air
Number of subjects: 86
Study: 18512752

Group type: EXPERIMENTAL
Intervention: Push and Release Test (P&R) in OFF medication state
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pull Test in OFF medication state
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Push and Release Test (P&R) in ON medication state
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pull Test in ON medication state
Number of subjects: 82
Study: 15687314

Group type: EXPERIMENTAL
Intervention: Oxygen plus continuous positive airway pressure
Number of subjects: 209

Group type: COMPARATOR
Intervention: Oxygen
Number of subjects: 209
Study: 12844138

Group type: EXPERIMENTAL
Intervention: Theophylline (250 mg twice daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10804140

Group type: EXPERIMENTAL
Intervention: Human caliciviruses (NLVs and SLVs)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Human caliciviruses (SLVs)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Astroviruses
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Enteric adenoviruses
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Rotaviruses
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Diagnosis with PCR and RT-PCR methods
Number of subjects: 832
Study: 8872646

Group type: EXPERIMENTAL
Intervention: Treadmill training
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 26
Study: 1310834

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (8 mg)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (4 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 19
Study: 2485268

Group type: EXPERIMENTAL
Intervention: Intravenous angiotensin II infusions (2-16 ng min-1 kg-1)
Number of subjects: 10
Study: 30659397

Group type: COMPARATOR
Intervention: Valenti technique
Number of subjects: 568

Group type: COMPARATOR
Intervention: Lichtenstein technique
Number of subjects: 568
Study: 29455058

Group type: EXPERIMENTAL
Intervention: Resistance training with physical activity (RPA group)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Resistance training (RT group)
Number of subjects: 41
Study: 27365472

Group type: EXPERIMENTAL
Intervention: Patient-matched positioning guides (PMPGs)
Number of subjects: 180
Study: 25255799

Group type: EXPERIMENTAL
Intervention: Patient oriented decision aid for prioritising treatment goals in diabetes
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Printed version of the decision aid
Number of subjects: 344

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study: 23364778

Group type: EXPERIMENTAL
Intervention: Infraclavicular block (Group I)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Supraclavicular block (Group S)
Number of subjects: 110
Study: 20425645

Group type: EXPERIMENTAL
Intervention: 12-week CBT skill training program delivered on a DVD
Number of subjects: 70

Group type: COMPARATOR
Intervention: General educational DVD program on dementia
Number of subjects: 70
Study: 18721510

Group type: COMPARATOR
Intervention: Edifoligide (placebo-controlled)
Number of subjects: 3014
Study: 16284203

Group type: EXPERIMENTAL
Intervention: CRT plus medical therapy
Number of subjects: 813

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 813
Study: 11910263

Group type: EXPERIMENTAL
Intervention: Fluoxetine (60 mg daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Imipramine (75 mg twice daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combination therapy with either fluoxetine or imipramine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Safety assessments
Number of subjects: 26
Study: 10622015

Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intra-articular injections
Number of subjects: 30
Study: 7852498

Group type: EXPERIMENTAL
Intervention: Ovine corticotropin-releasing hormone (CRH) 100 micrograms iv bolus
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Human corticotropin-releasing hormone (CRH) 100 micrograms iv bolus
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cushing's disease (both CRH types)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ovine CRH
Number of subjects: 10

Group type: COMPARATOR
Intervention: Human CRH
Number of subjects: 10

Group type: COMPARATOR
Intervention: Adrenal tumors (both CRH types)
Number of subjects: 10
Study: 1952268

Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (600 mg in 250 mL saline infused over six hours)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PET scan
Number of subjects: 5

Group type: COMPARATOR
Intervention: Plethysmography
Number of subjects: 5

Group type: COMPARATOR
Intervention: Blood samples
Number of subjects: 5
Study: 6993111

Group type: EXPERIMENTAL
Intervention: Triple dye
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Castile soap
Number of subjects: 0
Study: 30772908

Group type: EXPERIMENTAL
Intervention: Peripheral perfusion-targeted resuscitation (normalizing capillary refill time)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Lactate level-targeted resuscitation (normalizing or decreasing lactate levels)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Peripheral perfusion-targeted resuscitation
Number of subjects: 424

Group type: COMPARATOR
Intervention: Lactate level-targeted resuscitation
Number of subjects: 424
Study: 29019559

Group type: EXPERIMENTAL
Intervention: Herniotomy without incising external oblique aponeurosis
Number of subjects: 800

Group type: COMPARATOR
Intervention: Herniotomy with incising external oblique aponeurosis
Number of subjects: 800
Study: 25335948

Group type: EXPERIMENTAL
Intervention: Nicotine challenge (smoking a nicotinized cigarette)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Nicotine abstinence (continuing to abstain from smoking)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Denicotinized cigarette
Number of subjects: 142
Study: 24820288

Group type: EXPERIMENTAL
Intervention: Capsaicin cream
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (inert lotion)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 22930487

Group type: EXPERIMENTAL
Intervention: Hydrocortisone 10-0-5-0 mg (treatment A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Hydrocortisone 10-5-5 mg (treatment B)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Prednisone 5 mg (treatment C)
Number of subjects: 18
Study: 19180569

Group type: EXPERIMENTAL
Intervention: Soy supplements (82 mg/day aglycone equivalents)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 17971234

Group type: EXPERIMENTAL
Intervention: Proctored ultrasound hands-on instruction
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group with no hands-on instruction
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Faculty group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Proctored ultrasound examinations
Number of subjects: 30
Study: 15144425

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study: 11148443

Group type: EXPERIMENTAL
Intervention: High calorie meal (842 kcal)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low calorie meal (582 kcal)
Number of subjects: 12
Study: 9648991

Group type: EXPERIMENTAL
Intervention: p-ANCA positivity in patients without pouchitis (50%)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: p-ANCA positivity in patients with pouchitis (68%)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: p-ANCA positivity in ulcerative colitis patients (46.9%)
Number of subjects: 49

Group type: COMPARATOR
Intervention: p-ANCA positivity in healthy controls (0%)
Number of subjects: 49
Study: 8025492

Group type: EXPERIMENTAL
Intervention: Randomized response technique (RR-technique)
Number of subjects: 2330

Group type: COMPARATOR
Intervention: Direct response to sensitive questions
Number of subjects: 2330
Study: 2809097

Group type: EXPERIMENTAL
Intervention: Biosynthetic natural sequence hGH (somatropin)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 0.10 mg/kg thrice weekly
Number of subjects: 200

Group type: COMPARATOR
Intervention: 0.06 mg/kg thrice weekly
Number of subjects: 200
Study: 793005

Group type: EXPERIMENTAL
Intervention: Amitriptyline tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluphenazine with nortriptyline (f/n) tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Amitriptyline)
Number of subjects: 0
Study: 31932368

Group type: EXPERIMENTAL
Intervention: MMV390048 (20 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MMV390048 (up to 120 mg)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: MMV390048 (tablet formulations)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31218346

Group type: EXPERIMENTAL
Intervention: Single-arm trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized comparative trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Progression-free survival as a primary or coprimary outcome
Number of subjects: 0
Study: 28278167

Group type: EXPERIMENTAL
Intervention: IC ECG guidance (n = 500)
Number of subjects: 1007

Group type: COMPARATOR
Intervention: Anatomical landmark guidance (n = 507)
Number of subjects: 1007
Study: 25935863

Group type: EXPERIMENTAL
Intervention: Liraglutide treatment (23 patients)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Untreated patients (7 patients)
Number of subjects: 30
Study: 24048550

Group type: EXPERIMENTAL
Intervention: Shared decision-making intervention (digital video disc and booklet)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Shared decision-making intervention
Number of subjects: 123

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 123
Study: 21529211

Group type: EXPERIMENTAL
Intervention: 1 hour with isoflurane
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1 hour with desflurane
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 4 hours with isoflurane
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 4 hours with desflurane
Number of subjects: 8
Study: 19740396

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive plus rotigotine (2 mg on days 1-3, 3 mg maintenance thereafter)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matching placebo patches (instead of rotigotine)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptive plus rotigotine
Number of subjects: 40
Study: 17578934

Group type: EXPERIMENTAL
Intervention: Daily positive mood states
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mood manipulations (Studies 2-5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive mood states
Number of subjects: 0